ATP5MC3 and neoplasm: Finally, CISD1, ATP5MC3, PGD, SLC7A11, ACSL3, and FANCD2 expression was confirmed to significantly correlate with tumor mutational burden (TMB), microsatellite instability (MSI), immune cell infiltration, cellular checkpoint dysfunction, and cancer sensitivity to drugs.